BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27816969)

  • 1. Anti-metastatic effect of the TM4SF5-specific peptide vaccine and humanized monoclonal antibody on colon cancer in a mouse lung metastasis model.
    Wu G; Kim D; Park BK; Park S; Ha JH; Kim TH; Gautam A; Kim JN; Lee SI; Park HB; Kim YS; Kwon HJ; Lee Y
    Oncotarget; 2016 Nov; 7(48):79170-79186. PubMed ID: 27816969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic effect of a peptide vaccine targeting TM4SF5 against colon cancer in a mouse model.
    Kwon S; Kim YE; Kim D; Park BK; Wu G; Kim TH; Choi SH; Kim DS; Kwon HJ; Lee Y
    Biochem Biophys Res Commun; 2013 May; 435(1):134-9. PubMed ID: 23624388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effect of a TM4SF5-specific monoclonal antibody against colon cancer in a mouse model.
    Kim YE; Kwon S; Wu G; Kim D; Park BK; Park JA; Choi KC; Kim DS; Kwon HJ; Lee Y
    Oncotarget; 2014 Sep; 5(18):8402-15. PubMed ID: 25268742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of an anti-TM4SF5 monoclonal antibody and its application in the detection of TM4SF5 as a possible marker of a poor prognosis in colorectal cancer.
    Park BK; Park JY; Kim TH; Kim D; Wu G; Gautam A; Maharjan S; Lee SI; Lee Y; Kwon HJ; Choi KC
    Int J Oncol; 2018 Jul; 53(1):275-285. PubMed ID: 29749436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention and therapy of hepatocellular carcinoma by vaccination with TM4SF5 epitope-CpG-DNA-liposome complex without carriers.
    Kwon S; Kim D; Park BK; Cho S; Kim KD; Kim YE; Park CS; Ahn HJ; Seo JN; Choi KC; Kim DS; Lee Y; Kwon HJ
    PLoS One; 2012; 7(3):e33121. PubMed ID: 22427965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A peptide-CpG-DNA-liposome complex vaccine targeting TM4SF5 suppresses growth of pancreatic cancer in a mouse allograft model.
    Park S; Kim D; Wu G; Jung H; Park JA; Kwon HJ; Lee Y
    Onco Targets Ther; 2018; 11():8655-8672. PubMed ID: 30584324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effect of a TM4SF5-specific peptide vaccine against colon cancer in a mouse model.
    Kwon S; Kim YE; Park JA; Kim DS; Kwon HJ; Lee Y
    BMB Rep; 2014 Apr; 47(4):215-20. PubMed ID: 24286311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibody targeting of the cell surface molecule TM4SF5 inhibits the growth of hepatocellular carcinoma.
    Kwon S; Choi KC; Kim YE; Ha YW; Kim D; Park BK; Wu G; Kim DS; Lee Y; Kwon HJ
    Cancer Res; 2014 Jul; 74(14):3844-56. PubMed ID: 24802189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-cancer Activity of Novel TM4SF5-Targeting Antibodies through TM4SF5 Neutralization and Immune Cell-Mediated Cytotoxicity.
    Ahn HM; Ryu J; Song JM; Lee Y; Kim HJ; Ko D; Choi I; Kim SJ; Lee JW; Kim S
    Theranostics; 2017; 7(3):594-613. PubMed ID: 28255353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic effects of TM4SF5-targeting chimeric and humanized monoclonal antibodies in hepatocellular and colon cancer models.
    Ko D; Kim E; Shin EA; Nam SH; Yoon J; Lee JS; Lee Y; Park S; Ha K; Choi SY; Lee JW; Kim S
    Mol Ther Oncolytics; 2022 Mar; 24():452-466. PubMed ID: 35211652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting TM4SF5 with anti-TM4SF5 monoclonal antibody suppresses the growth and motility of human pancreatic cancer cells.
    Park S; Kim D; Park JA; Kwon HJ; Lee Y
    Oncol Lett; 2020 Jan; 19(1):641-650. PubMed ID: 31897180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting metastatic breast cancer with peptide epitopes derived from autocatalytic loop of Prss14/ST14 membrane serine protease and with monoclonal antibodies.
    Kim KY; Yoon M; Cho Y; Lee KH; Park S; Lee SR; Choi SY; Lee D; Yang C; Cho EH; Jeon SD; Kim SH; Kim C; Kim MG
    J Exp Clin Cancer Res; 2019 Aug; 38(1):363. PubMed ID: 31426843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapy.
    Yao HP; Feng L; Suthe SR; Chen LH; Weng TH; Hu CY; Jun ES; Wu ZG; Wang WL; Kim SC; Tong XM; Wang MH
    J Immunother Cancer; 2019 Mar; 7(1):75. PubMed ID: 30871619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential inhibition of transmembrane 4 L six family member 5 (TM4SF5)-mediated tumorigenesis by TSAHC and sorafenib.
    Lee SA; Lee MS; Ryu HW; Kwak TK; Kim H; Kang M; Jung O; Kim HJ; Park KH; Lee JW
    Cancer Biol Ther; 2011 Feb; 11(3):330-6. PubMed ID: 21099346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transmembrane 4 L six family member 5 (TM4SF5) enhances migration and invasion of hepatocytes for effective metastasis.
    Lee SA; Kim TY; Kwak TK; Kim H; Kim S; Lee HJ; Kim SH; Park KH; Kim HJ; Cho M; Lee JW
    J Cell Biochem; 2010 Sep; 111(1):59-66. PubMed ID: 20506553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of immunological memory response by vaccination with TM4SF5 epitope-CpG-DNA-liposome complex in a mouse hepatocellular carcinoma model.
    Kwon S; Kim D; Park BK; Wu G; Park MC; Ha YW; Kwon HJ; Lee Y
    Oncol Rep; 2013 Feb; 29(2):735-40. PubMed ID: 23138455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
    Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
    Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.
    Sack U; Walther W; Scudiero D; Selby M; Kobelt D; Lemm M; Fichtner I; Schlag PM; Shoemaker RH; Stein U
    J Natl Cancer Inst; 2011 Jul; 103(13):1018-36. PubMed ID: 21685359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of four-transmembrane L6 family member 5 (TM4SF5)-mediated tumorigenicity in hepatocytes by a synthetic chalcone derivative.
    Lee SA; Ryu HW; Kim YM; Choi S; Lee MJ; Kwak TK; Kim HJ; Cho M; Park KH; Lee JW
    Hepatology; 2009 Apr; 49(4):1316-25. PubMed ID: 19177595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of tetraspan(in) TM4SF5 with CD44 promotes self-renewal and circulating capacities of hepatocarcinoma cells.
    Lee D; Na J; Ryu J; Kim HJ; Nam SH; Kang M; Jung JW; Lee MS; Song HE; Choi J; Lee GH; Kim TY; Chung JK; Park KH; Kim SH; Kim H; Seo H; Kim P; Youn H; Lee JW
    Hepatology; 2015 Jun; 61(6):1978-97. PubMed ID: 25627085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.